Roche and C4 Therapeutics Forge Strategic Alliance to Pioneer Degrader-Antibody Conjugates for Novel Cancer Therapies Roche, a global pharmaceutical giant,…
Read More
Johns Hopkins Researchers Discover How Gene Fusion Droplets Drive Rare Kidney Cancer Progression
In a landmark study published in the journal Cell Reports on April 22, investigators at the Johns Hopkins Kimmel Cancer…
Read More
Deciphering the Distinct Roles of BET Proteins: A New Paradigm for Targeted Cancer Therapy Emerges from Max Planck Research
The global fight against cancer, a disease projected to claim over 10 million lives annually, continues to drive intense research…
Read More
Snail-Inspired Soft Robots Poised to Revolutionize Precision Drug Delivery for Cancer and Beyond
Inspired by the remarkable locomotion of gastropods, a pioneering drug delivery project led by the University of Manchester has secured…
Read More
European Commission Approves Keytruda Combination Therapy for PD-L1-Positive Platinum-Resistant Ovarian Cancer
The European Commission (EC) has granted approval for Keytruda (pembrolizumab) in combination with paclitaxel, with or without bevacizumab, as a…
Read More
Houston Methodist Researchers Identify TDP43 Protein as a Primary Regulator of DNA Mismatch Repair Linking Neurodegeneration and Cancer
In a landmark study that bridges the traditionally separate fields of neurology and oncology, researchers at the Houston Methodist Research…
Read More
Ludwig Cancer Research Study Identifies Novel Combination Therapy to Overcome Differentiation Block in Acute Myelogenous Leukemia
The landscape of hematological oncology is facing a potential paradigm shift following a comprehensive study led by Ludwig Cancer Research,…
Read More
Johns Hopkins Researchers Unveil Groundbreaking Epigenetic Instability Index to Revolutionize Early Cancer Detection Through Advanced Liquid Biopsy
A pioneering development from researchers at the Johns Hopkins Kimmel Cancer Center is set to significantly enhance the accuracy and…
Read More
Transforming immune cells into cancer-seeking ‘bloodhounds’ to eliminate tumors
A groundbreaking study by Stanford Medicine researchers has unveiled a novel immunotherapy approach that could revolutionize the treatment of solid…
Read More
Telomir Pharmaceuticals Submits Investigational New Drug Application for Telomir-1 to FDA for Advanced Triple-Negative Breast Cancer
Telomir Pharmaceuticals has taken a significant stride in its mission to combat advanced and metastatic triple-negative breast cancer (TNBC) by…
Read More
